Home / Knowledge hub /
Addressing the challenges of vaccines and intradermal delivery
January 8, 2020
Download this article for considerations of six shortcomings in vaccine development as it relates to intradermal delivery and thoughts on the industry can address these gaps:
- Where vaccines are delivered in the body
- Practical difficulties with intradermal delivery
- Delivery volume
- Scale-up
- Cold chain requirements
- Non-representative clinical trials
Get Your Copy Now
Fields marked with a * are required.
Related resources
Explore our other resources to discover valuable insights on the latest trends in drug delivery.
Live-Attenuated VEEV vaccine delivered by iDNA using microneedles is immunogenic in rabbits
Learn More
Kindeva drug delivery – microneedles
Learn More
Kindeva Drug Delivery world vaccine congress presentation
Learn MoreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.